Potential bidders for Symbion’s assets have phoned Terry White chemist founder Terry White to ease pharmacists’ fears about their fate under new ownership.
The Terry White pharmacy chain contributes revenue of $350 million to $400 million a year to parent company Symbion.
White last week told The Australian Financial Review that some potential bidders had not contacted him and were “ignorant and arrogant if they believe they can move into the health-care sector without negotiating with people who are running the pharmacies”.
White today told the AFR that all bidders had since contacted him and were keen to discuss their proposals with pharmacists once they had proceeded to due diligence and were free of confidentiality agreements currently in place.
Potential bidders include Ironbride and Archer Capital (jointly), Metcash and Sigma (jointly) and Australian Pharmaceutical Industries.
You can help keep SmartCompany free for everyone to read
Small and medium businesses and startups have never needed credible, independent journalism and information more than now.
That’s our job at SmartCompany: to keep you informed with the news, interviews and analysis you need to manage your way through this unprecedented crisis.
Now, there’s a way you can help us keep doing this: by becoming a SmartCompany Supporter.
Even a small contribution will help us to keep doing the journalism that keeps Australia’s entrepreneurs informed.
And it’s not all one-way traffic either. SmartCompany Super Supporters get to dial into our monthly editor’s meeting and attend a monthly, invite-only webinar with a big-name entrepreneur.